The Auric innovation Grant

SUPPORTING A WORLD-FIRST PERSONALISED THERAPY PLATFORM FOR METASTATIC BREAST CANCER

The 2022 Auric Innovation grant was awarded to Professor Gary Richardson OAM, whose collaborative project will produce a world-first personalised therapy platform for metastatic breast cancer.

Chairman of the Cabrini Foundation Board, Sylvia Falzon said the judging panel followed a rigorous independent review process, and ultimately reached a unanimous decision.

“Prof Richardson’s application is an exceptional and worthy recipient of the $200,000 Auric Innovation grant,” Ms Falzon said.

“It will put Cabrini on the world stage for novel and cutting-edge advances in precision medicine.”

The work will be undertaken as a Cabrini and Monash University collaboration, ensuring the brightest minds are working together.

Lee and Brian Johnstone are passionate about fostering a culture of innovation throughout Cabrini to improve patient and staff experience. To ensure true innovative change, they have developed the Auric (meaning ‘gold’) Innovation Grant worth $200,000, which they have generously awarded for the past four years.

Cabrini Chief Executive, Sue Williams welcomed the announcement, saying Prof Richardson’s application embodied the meaning and intent of the grant – a BIG IDEA, Impact and Outcomes

“I commend Gary for his pursuit of better outcomes for women who have metastatic breast cancer, which is such a difficult cancer to treat,” she said.

“Development of the platform will eventually be a part of personalised medicine available to all women with metastatic breast cancer.

“This will lead to national and international collaborations and help attract the brightest researchers and clinicians to work with Cabrini.”

Cabrini Foundation thanks donors Lee and Brian Johnstone for their significant contribution to the Foundation research grant fund.